Among these predicted miR-30b-5p and miR-30e-5p targets, KRAS, MYO5A and SLC4A7 were also validated to be altered in different HNSCC cell lines, in which KRAS was further validated as the target genes. This evidence concerns the gene KRAS and head and neck squamous cell carcinoma.